Apexbio Technology LLC ICATIBANT-ACETATE-25MG
Icatibant Acetate (CAS No 138614-30-9) is a synthetic peptide and a selective bradykinin B2 receptor antagonist used in biomedical research for its ability to inhibit bradykinin-induced responses Originating from efforts to manage hereditary angioedema it acts by blocking the B2 receptor pathway preventing vasodilation and vascular permeability Its in vitro activity is observed in the nanomolar range It is commonly applied in cell-based assays animal models and drug screening to explore inflammatory responses and vascular permeability Experimental concentrations typically depend on the specific research design